Soluble Urokinase Plasminogen Activator Receptor is Associated With Inflammation in the Vulnerable Human Atherosclerotic Plaque.
(2012) In Stroke: a journal of cerebral circulation 43(12). p.3305-3312- Abstract
- Recently, plasma soluble urokinase plasminogen activator receptor (suPAR) has gained interest as a marker of cardiovascular risk. suPAR is released through the cleavage of urokinase plasminogen activator receptor (uPAR), which is found in monocytes, activated T-lymphocytes and endothelial cells, all involved in atherosclerosis. suPAR levels have been well studied in plasma, but no studies have focused on suPAR in human atherosclerotic plaques. The aim of this study was to determine whether suPAR measured in the plaque is associated with symptomatic plaques and plaque inflammation.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3218966
- author
- Edsfeldt, Andreas LU ; Nitulescu, Mihaela LU ; Grufman, Helena LU ; Grönberg, Caitriona LU ; Persson, Ana LU ; Nilsson, Marie MN LU ; Persson, Margaretha LU ; Björkbacka, Harry LU and Goncalves, Isabel LU
- organization
- publishing date
- 2012
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Stroke: a journal of cerebral circulation
- volume
- 43
- issue
- 12
- pages
- 3305 - 3312
- publisher
- American Heart Association
- external identifiers
-
- wos:000311497600035
- pmid:23150653
- scopus:84870876982
- pmid:23150653
- ISSN
- 1524-4628
- DOI
- 10.1161/STROKEAHA.112.664094
- language
- English
- LU publication?
- yes
- id
- aaf0c8d5-fb55-4e60-90da-78908533e062 (old id 3218966)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/23150653?dopt=Abstract
- date added to LUP
- 2016-04-04 09:44:47
- date last changed
- 2022-09-29 07:32:30
@article{aaf0c8d5-fb55-4e60-90da-78908533e062, abstract = {{Recently, plasma soluble urokinase plasminogen activator receptor (suPAR) has gained interest as a marker of cardiovascular risk. suPAR is released through the cleavage of urokinase plasminogen activator receptor (uPAR), which is found in monocytes, activated T-lymphocytes and endothelial cells, all involved in atherosclerosis. suPAR levels have been well studied in plasma, but no studies have focused on suPAR in human atherosclerotic plaques. The aim of this study was to determine whether suPAR measured in the plaque is associated with symptomatic plaques and plaque inflammation.}}, author = {{Edsfeldt, Andreas and Nitulescu, Mihaela and Grufman, Helena and Grönberg, Caitriona and Persson, Ana and Nilsson, Marie MN and Persson, Margaretha and Björkbacka, Harry and Goncalves, Isabel}}, issn = {{1524-4628}}, language = {{eng}}, number = {{12}}, pages = {{3305--3312}}, publisher = {{American Heart Association}}, series = {{Stroke: a journal of cerebral circulation}}, title = {{Soluble Urokinase Plasminogen Activator Receptor is Associated With Inflammation in the Vulnerable Human Atherosclerotic Plaque.}}, url = {{http://dx.doi.org/10.1161/STROKEAHA.112.664094}}, doi = {{10.1161/STROKEAHA.112.664094}}, volume = {{43}}, year = {{2012}}, }